Analogic Corporation
ANALOGIC CORP (Form: 4, Received: 09/18/2017 19:19:06)
FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Faltas Mervat
2. Issuer Name and Ticker or Trading Symbol

ANALOGIC CORP [ ALOG ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      _____ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
Sr VP & GM-OEM Medical Group
(Last)          (First)          (Middle)

C/O ANALOGIC CORPORATION, 8 CENTENNIAL DRIVE
3. Date of Earliest Transaction (MM/DD/YYYY)

9/14/2017
(Street)

PEABODY, MA 01960
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   9/14/2017     M    1166   A   (3) 9908   D    
Common Stock   9/14/2017     F    379   D $77.15   9529   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units     (1) 9/14/2017     A     V 4557         (1)   (1) Common Stock   4557   $0.00   4557   D    
Restricted Stock Units     (2) 9/14/2017     A      2269         (2)   (2) Common Stock   2269   $0.00   2269   D    
Restricted Stock Units     (3) 9/14/2017     M         1166      (3)   (3) Common Stock   1166     (3) 0   D    

Explanation of Responses:
(1)  The number of Restricted Stock Units ("RSUs)" represents the target number of RSUs that may be earned based on the achievement of certain performance criteria. The actual number of RSUs awarded will vary depending on the Company's performance. The performance period will end on July 31, 2020. Thereafter, a determination will be made as to whether and to what extent the performance criteria has been met. If such criteria has been met, the RSUs earned will be converted to common stock and a like number of shares will be issued to the grantee.
(2)  The time-based RSUs will cliff vest on July 31, 2020. On that date, the RSUs will be converted to common stock and a like number of shares will be issued to the grantee.
(3)  Represents the vesting of performance-based award granted on 9/08/14.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Faltas Mervat
C/O ANALOGIC CORPORATION
8 CENTENNIAL DRIVE
PEABODY, MA 01960


Sr VP & GM-OEM Medical Group

Signatures
/s/ John J. Fry, by Power of Attorney For Mervat Faltas 9/18/2017
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.